M13
VC Fund
Santa Monica, United States
M13 is a VC fund in Santa Monica focused on Software and Health Care. M13 provides strategic counsel and operational expertise to help founders grow their companies. Through Fund II, M13 will expand its focus to emerging technologies driving change in consumer behavior over the next decade. Founded in 2016 with offices in Los Angeles, New York, and San Francisco.
- Total investments:
- 258
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $8M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries M13 invests in
Stages M13 invests in
Countries M13 invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Seed
- $2M–$9.8M
- Series A
- $8M–$35M
- Series B
- $21M–$70M
Investment Focus
Industry
- Software 31 (12%)
- Health Care 26 (10%)
- Artificial Intelligence 23 (9%)
- Internet 20 (8%)
- E-Commerce 20 (8%)
Stage
- Seed 82 (32%)
- Series A 62 (24%)
- Series B 21 (8%)
- Pre-Seed 13 (5%)
- Venture - Series Unknown 10 (4%)
Country
- United States 153 (59%)
- Canada 5 (2%)
- Chile 1 (0%)
- China 1 (0%)
- Spain 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christine Choi
Partner
|
Partner | Total investments: 1 | Find email | |
Courtney Reum
Partner, Co-Founder
|
Partner, Co-Founder | Total investments: 5 | Find email | |
Karl Alomar
Managing Partner
|
Managing Partner | Total investments: 11 | Find email | |
Latif Peracha
General Partner
|
General Partner | Total investments: 25 | Find email | |
Matt Hoffman
Partner, Head of Talent
|
Partner, Head of Talent | Total investments: 4 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Baselayer automates business risk assessment and eliminates B2B fraud in the financial sector. It offers services such as business verification (KYB), fraud detection, business onboarding optimization, risk profiling, portfolio monitoring & alerting, and workflow automation. Baselayer empowers 100s of financial institutions, governmentagencies, lenders, and fintech to unlock instant trust with any business in America. | $35M / Series A / Sep 22, 2026 | ||
| Ayble is a clinically-backed digital health platform that uses data-driven machine learning technology to provide comprehensive, precision dietary analysis and holistic care for people with GI conditions. | $16M / Series A / Sep 16, 2026 | ||
| Baselayer automates business risk assessment and eliminates B2B fraud in the financial sector. It offers services such as business verification (KYB), fraud detection, business onboarding optimization, risk profiling, portfolio monitoring & alerting, and workflow automation. Baselayer empowers 100s of financial institutions, governmentagencies, lenders, and fintech to unlock instant trust with any business in America. | $20M / Series A / Aug 10, 2026 | ||
| Skyfall AI builds AI-driven Enterprise Super Intelligence, so that businesses can plan, decide, and operate by themselves efficiently. | Seed / Jul 20, 2026 | ||
| Rime develops speech technologies for a wide range of customers. The company works on speech generation with a deep understanding of linguistic and sociolinguistic phenomena needed to create the next generation of text-to-speech tooling. | $24M / Series A / Jul 15, 2026 | ||
| Chord is an AI-native data platform for the agentic commerce era. It unifies commerce data in the Data Foundation, layers in the context AI needs to be accurate, reliable, and relevant via the Context Stack, and deploys Agents that optimize spend, refine audiences, and take action across your commerce stack. | $7M / Venture - Series Unknown / Apr 29, 2026 | ||
| Tamber is an AI-powered creative suite for musicians. It acts as a "bionic arm" that enhances production workflows using sonic intelligence for real-time sound control via text, voice, or gestures. | $5M / Seed / Apr 23, 2026 | ||
| OpenFX is redefining the future of global money movement. We enable money to flow across borders as effortlessly as data, unbound by time zones, legacy systems, or banking hours. Our FX infrastructure transforms how finance teams operate, delivering cross-border transfers with industry-leading spreads, real-time settlement and 24/7availability. We are a team of serial entrepreneurs from Affirm, BofA, Charles Schwab, Goldman Sachs, Intuit, JPM, Kraken, Microsoft, Meta, PayPal, and Slack. | $94M / Series A / Mar 31, 2026 | ||
| Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients. | $17M / Seed / Mar 31, 2026 | ||
| Luminos AI provides software for legal and governance teams to assess and manage AI risk. The platform supports compliance testing, evaluation workflows, and automated reporting across classical, generative, and agentic AI systems. | $7.8M / Venture - Series Unknown / Feb 24, 2026 | ||
| See all 258 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does M13 invest in?
M13 invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 258 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is M13's check size?
M13 typically joins rounds of $2M–$9.8M at Seed, $8M–$35M at Series A and $21M–$70M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds M13 participates in.
How do I contact M13?
Public channels for M13 include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at M13?
The team at M13 includes Christine Choi (Partner), Courtney Reum (Partner, Co-Founder) and Karl Alomar (Managing Partner), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
